IRCT201509031031N17已完成1 期
A phase I clinical trial on the use of autologous bone marrow mesenchymal stem cells for treatment of chronic kidney disease
Department of Regenerative Biomedicine, Cell Science Research Center, Royan Institute for Stem Cell0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 40 years 至 60 years（—）
- 性别
- All
入选标准
- •Inclusion Criteria: CKD confirmed with serum and urine analysis and GFR 25-60 mL/min; Male and Female; CKD (more than 3 months with increased and irreversible creatinine) symptoms; Patients with controlled hypertension; Patient's age between 40-60 years; Ability to understand and willingness to sign consent form
排除标准
- •Pregnant or lactating; Vascular disease; Diabetes mellitus; Other systemic disease such as malignancy, autoimmune disease, hematologic disease, liver disease and …; Chronic rejection in transplantation; Life expectancy less than 2 years; Allergy to any ingredients used in cell culture; Congenital or acquired obstructive chronic renal failure; Unable to attend at follow up visits
研究者
相似试验
终止
1 期
A clinical trial of adoptive T-cell immunotherapy for patients with Epstein-Barr virus-associated nasopharyngeal carcinoma.Metastatic nasopharyngeal carcinomaCancer - Head and neckACTRN12613000866707QIMR Berghofer Medical Research Institute18
招募中
1 期
A phase I/II clinical study of expanded autologous NK cell combined with rituximab-based chemotherapy in patients with CD20 positive B-cell lymphomarelapsed/refractory CD20 positive B-cell lymphomaJPRN-UMIN000014072Department of Hematology, Tokyo Women's Medical University10
已完成
1 期
This study is assessing the feasibility of generating expanded T cells for the treatment of cytomegalovirus (CMV) reactivation and disease, and the subsequent evaluation of safety.CytomegalovirusInfection - Other infectious diseasesACTRN12613000981729QIMR Berghofer Medical Research Institute.30
已完成
不适用
Does autologous platelet rich plasma help in improvement of vision in patients of retinitis pigmentosa?CTRI/2021/10/037501GSVM Medical College39
已完成
不适用
Investigator-initiated clinical trial: Autologous peripheral blood-derived CD34+ cells transplantation for bone and vascular regeneration using with MB-001 and IK-02 in patients with Fracture non-union.Fracture non-unionJPRN-UMIN000022814Foundation for Biomedical Research and Innovation at Kobe15